Viewing Study NCT00112827


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-02-28 @ 5:28 AM
Study NCT ID: NCT00112827
Status: COMPLETED
Last Update Posted: 2025-06-06
First Post: 2005-06-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Multiple Myeloma View
None Smoldering Multiple Myeloma View
None Stage I Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage III Multiple Myeloma View
Keywords: